Industry is gathering scientific data to approach the regulator, DCGI, for a review of the suspension order.
.jpg)
The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country.
Serving pilots question the Kozhikode plane crash report findings.
Govt bans brands with annual sales worth Rs 3,728 crore.
Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.
Indian pharma firms under European drug regulator's scanner.
